. . "Lemr, Karel" . "In vitro biotransformation of 2,6,9-trisubstituted purine-derived cyclin-dependent kinase ihibitor bohemine by mouse liver microsomes"@en . "Cyclin-dependent kinase inhibitors; cytochromes P-450; glycosylations; microcomes; liver; kidney"@en . "11"^^ . "In vitro biotransformation of 2,6,9-trisubstituted purine-derived cyclin-dependent kinase ihibitor bohemine by mouse liver microsomes" . "15110" . . . . . "\u010Cervenkov\u00E1, Kate\u0159ina" . . . "[720DF7464839]" . "N\u011Bkolik typ\u016F selektivn\u00EDch inhibitor\u016F Cdk byly navr\u017Eeny jako nov\u00E1 \u010Dinidla pro molekul\u00E1rn\u011B-biologick\u00E9, biochemick\u00E9 a morfologick\u00E9 studie bun\u011B\u010Dn\u00E9ho cyklu."@cs . "Vesel\u00FD, Jaroslav" . "Rypka, Miroslav" . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . . "Luke\u0161, Ji\u0159\u00ED" . "Chmela, Zden\u011Bk" . "15"^^ . . . "1366-5928" . "In vitro biotransformation of 2,6,9-trisubstituted purine-derived cyclin-dependent kinase ihibitor bohemine by mouse liver microsomes"@en . "RIV/61989592:15110/02:00007082!RIV09-MSM-15110___" . "RIV/61989592:15110/02:00007082" . . "Havl\u00ED\u010Dek, Libor" . "P(OC B17.20), Z(MSM 151100001)" . "Hanu\u0161, Jan" . . "11" . "In vitro biotransformace 2,6,9-trisubstituovan\u00E9ho deriv\u00E1ty purinu, inhibitoru cyklin dependentn\u00ED kin\u00E1zy boheminu my\u0161\u00EDmi jatern\u00EDmi mikrosomy."@cs . . . "\u010Cern\u00FD, B." . "Recently, several types of selective synthetic inhibitors of cyclin-dependent kinases (CDKs) have been implicated as novel and invaluable reagents for molecular biological, biochemical and morphological studies of the cell cycle (reviewed in Meijer at al. 1999, Sielecki at al. 2000)." . . . "32" . "In vitro biotransformace 2,6,9-trisubstituovan\u00E9ho deriv\u00E1ty purinu, inhibitoru cyklin dependentn\u00ED kin\u00E1zy boheminu my\u0161\u00EDmi jatern\u00EDmi mikrosomy."@cs . . . "Xenobiotica" . . "Michal\u00EDkov\u00E1, K." . . "Recently, several types of selective synthetic inhibitors of cyclin-dependent kinases (CDKs) have been implicated as novel and invaluable reagents for molecular biological, biochemical and morphological studies of the cell cycle (reviewed in Meijer at al. 1999, Sielecki at al. 2000)."@en . . "Riegrov\u00E1, Dagmar" . . . . "In vitro biotransformation of 2,6,9-trisubstituted purine-derived cyclin-dependent kinase ihibitor bohemine by mouse liver microsomes" . "648633" . "6"^^ .